These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reliability of the Blessed Telephone Information-Memory-Concentration Test. Kawas C; Karagiozis H; Resau L; Corrada M; Brookmeyer R J Geriatr Psychiatry Neurol; 1995 Oct; 8(4):238-42. PubMed ID: 8561839 [TBL] [Abstract][Full Text] [Related]
3. Olanzapine does not enhance cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementia. Kennedy J; Deberdt W; Siegal A; Micca J; Degenhardt E; Ahl J; Meyers A; Kaiser C; Baker RW Int J Geriatr Psychiatry; 2005 Nov; 20(11):1020-7. PubMed ID: 16250069 [TBL] [Abstract][Full Text] [Related]
4. The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic. Brodaty H; Moore CM Int J Geriatr Psychiatry; 1997 Jun; 12(6):619-27. PubMed ID: 9215942 [TBL] [Abstract][Full Text] [Related]
5. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits. Kashiwa Y; Kitabayashi Y; Narumoto J; Nakamura K; Ueda H; Fukui K Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246 [TBL] [Abstract][Full Text] [Related]
6. Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia. Chibnall JT; Tait RC; Harman B; Luebbert RA J Am Geriatr Soc; 2005 Nov; 53(11):1921-9. PubMed ID: 16274373 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal changes in cognitive functioning in adult day care participants. Cohen-Mansfield J; Gruber-Baldini AL; Culpepper WJ; Werner P J Geriatr Psychiatry Neurol; 1996 Jan; 9(1):30-8. PubMed ID: 8679061 [TBL] [Abstract][Full Text] [Related]
8. Depression in dementia of the Alzheimer type and in multi-infarct dementia. Fischer P; Simanyi M; Danielczyk W Am J Psychiatry; 1990 Nov; 147(11):1484-7. PubMed ID: 2221160 [TBL] [Abstract][Full Text] [Related]
9. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Modrego PJ; Ferrández J Arch Neurol; 2004 Aug; 61(8):1290-3. PubMed ID: 15313849 [TBL] [Abstract][Full Text] [Related]
10. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study. Rocca P; Marino F; Montemagni C; Perrone D; Bogetto F Psychiatry Clin Neurosci; 2007 Dec; 61(6):622-9. PubMed ID: 18081622 [TBL] [Abstract][Full Text] [Related]
11. Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale. Cullum CM; Saine K; Chan LD; Martin-Cook K; Gray KF; Weiner MF Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):103-8. PubMed ID: 11417663 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD). Gareri P; Cotroneo A; Lacava R; Seminara G; Marigliano N; Loiacono A; De Sarro G Arch Gerontol Geriatr Suppl; 2004; (9):207-15. PubMed ID: 15207416 [TBL] [Abstract][Full Text] [Related]
14. Comparative study of aprosody in Alzheimer's disease and in multi-infarct dementia. Pérez Trullen JM; Modrego Pardo PJ Dementia; 1996; 7(2):59-62. PubMed ID: 8866676 [TBL] [Abstract][Full Text] [Related]
15. Dementia rating scale performance: a comparison of vascular and Alzheimer's dementia. Lukatela KA; Cohen RA; Kessler HA; Jenkins MA; Moser DJ; Stone WF; Gordon NF; Kaplan RF J Clin Exp Neuropsychol; 2000 Aug; 22(4):445-54. PubMed ID: 10923054 [TBL] [Abstract][Full Text] [Related]
16. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease. Ito T; Meguro K; Akanuma K; Meguro M; Lee E; Kasuya M; Ishii H; Mori E J Clin Neurosci; 2007 Sep; 14(9):850-5. PubMed ID: 17587584 [TBL] [Abstract][Full Text] [Related]
17. Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia. Tanaka N; Nakatsuka M; Ishii H; Nakayama R; Hosaka R; Meguro K Psychogeriatrics; 2013 Dec; 13(4):199-205. PubMed ID: 24289460 [TBL] [Abstract][Full Text] [Related]
18. [Efficacy of atypical antipsychotics in patients with Alzheimer's dementia. CATIE-AD-Study (Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer's Disease)]. Förstl H Internist (Berl); 2007 Jun; 48(6):642-4. PubMed ID: 17497111 [No Abstract] [Full Text] [Related]
19. Development and validation of the Greek severe impairment battery (SIB). Konsta A; Bonti E; Parlapani E; Athanasiadis L; Kechayas P; Karagiannidou M; Fokas K Int Psychogeriatr; 2014 Apr; 26(4):591-6. PubMed ID: 24443975 [TBL] [Abstract][Full Text] [Related]
20. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study. Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]